Hybrid Gamma Camera Imaging: Translation from Bench to Bedside

Total Page:16

File Type:pdf, Size:1020Kb

Hybrid Gamma Camera Imaging: Translation from Bench to Bedside Hybrid Gamma Camera Imaging: Translation from Bench to Bedside A thesis submitted to the University of Nottingham for the degree of Doctor of Philosophy by Aik Hao Ng MMed.Phys. Radiological Sciences, Division of Clinical Neuroscience, School of Medicine September 2017 Declaration I, Aik Hao Ng declare that the work presented in this thesis is my own original work based on the research undertaken during my PhD study period unless otherwise referenced or acknowledged. ii “Life is like riding a bicycle. To keep your balance, you must keep moving.” - Albert Einstein Abstract There is increasing interest in the use of small field of view (SFOV) portable gamma cameras in medical imaging. A novel hybrid optical-gamma camera (HGC) has been developed through a collaboration between the Universities of Leicester and Nottingham. This system offers high resolution gamma and optical imaging and shows potential for use at the patient bedside, or in the operating theatre. The aim of this thesis was to translate the HGC technology from in vitro laboratory studies to clinical use in human subjects. Pilot studies were undertaken with the HGC as part of this thesis. Furthermore, efforts have been made to transform the HGC technologies into a new medical device, known as Nebuleye. Initial physical evaluation of the pre-production prototype camera was carried out as part of the device developmental process, highlighting some aspects of the design that require further modification. A complete and rigorous testing scheme to assess the pre-production prototype camera has been developed and successfully implemented. The newly introduced tests enabled the system uniformity, system sensitivity, detector head shielding leakage, optical-gamma image alignment and optical image quality of the hybrid camera to be assessed objectively. This harmonised testing scheme allows characterisation and direct comparison of SFOV gamma cameras. In vitro and in vivo preclinical imaging was undertaken to examine the performance of the SFOV gamma cameras for experimental animal studies. The results of animal study have shown for the first time the feasibility and performance of these SFOV gamma cameras for imaging mice injected with a newly developed 111In labelled hybrid tracer. Further investigations are needed to improve the system resolution and prepare the camera system for combined gamma-near infrared fluorescence imaging in future. A systematic in vitro laboratory assessment method has been established to examine the imaging performance of the SFOV gamma camera in radioguided sentinel lymph node biopsy (SLNB) and radioactive seed localisation procedures for breast cancer surgery. Further preparatory work was undertaken to carry out a pilot clinical trial of iv Abstract| v the use of the pre-production prototype camera in sentinel node localisation procedures during breast cancer surgery. The clinical study protocol and routine quality control procedures have been established and are suitable for future use. Baseline data on the camera performance assessed using the routine quality control scheme have been obtained. Finally, the capabilities of the SFOV gamma camera were assessed. This has provided baseline data on user feedback and the imaging consequences on operator motion effects, as well as examining the detectability of a range of radionuclides, including 99mTc, 111In, 123I, 125I and 75Se. The first clinical results of the use of the HGC in clinical hybrid optical-gamma imaging in patients administered with 99mTc and 123I labelled radiopharmaceuticals have been reported. This clinical study has demonstrated the feasibility and capability of HGC in various clinical applications performed at the patient bedside, which included patients undergoing bone, thyroid, lacrimal drainage and lymphatic imaging as well as DaTscan studies. In conclusion, the work in this thesis has demonstrated the successful translation of an SFOV hybrid gamma camera for clinical use. This system would be ideally suited for use in the operating theatre for radioguided procedures such as sentinel node detection and tumour localisation. This system also offers potential for use with the new generation of hybrid fluorescent-radionuclide tracers currently under development. Acknowledgements In autumn 2013, I left my comfort zone, full with family and friends love, and the nice hot weather that I am familiar with, to a four seasons country to embark on my PhD journey. From that time point, I knew it would be a tough doctoral world, from settling my family and myself in the new environment, to the discovery of sciences in my study field. I consider myself very fortunate indeed to have the opportunity to meet so many wonderful people and have had an enriched life experience in the United Kingdom. There are many organisations or people whom I would like to express my sincere gratitude for their help and support along my PhD journey. Firstly, I would like to thank my three supervisors, Professor Alan C. Perkins, Professor John E. Lees and Professor Paul S. Morgan for sharing their knowledge and experiences. Without their advice and guidance, this thesis would not be possible. I am fortunate to have had the opportunity to work with Professor Alan C. Perkins, an experienced leader in the world of nuclear medicine. He has been a wonderful mentor, supervisor and friend. His broad knowledge and experience in medical physics as well as his patience in imparting wisdom to me are inspirational. Thanks for giving me the opportunities to extend my professional horizon in regional research collaboration. I also express my heartfelt gratitude to him for the time and effort he had to spend to discuss, proofread and correct my thesis. I would like to thank Professor John E. Lees for his generosity and kindness in sharing his vast knowledge and expertise in the Hybrid Gamma Camera (HGC) technology and loaning me the camera and other necessary equipment for my experimental work. His enormous efforts in innovation and strong leadership has led the research team to develop a better camera for patient benefit. I would also like to thank Professor Paul S. Morgan for his advice and help with the image processing work and the use of MOCO software used in the operator motion effect study. He is a good friend and supervisor who provides continuous support and guidance whenever I needed during my study. Secondly, I would like to thank the colleagues from Space Research Centre, University of Leicester that worked together on this camera development and clinical trial, who vi Acknowledgement| vii were willing to share their knowledge and experience with me. They included Sarah Bugby, Bahadar Bhatia, Mohammed Alqahtani, Layal Jambi, Numan Dawood and William McKnight. My heartfelt thanks to Dr. Bugby for sharing her expertise in HGC technology, answering all my questions patiently, performing the preclinical radionuclide-NIRF imaging at Leiden University Medical Centre (LUMC) alongside me and proofreading my thesis. Special thanks to Layal Lambi who provided raw image data for HGC intrinsic sensitivity, uniformity and spatial resolution tests. I would also like to thank Mohammed Alqahtani for bringing the camera to Queen’s Medical Centre for experimental use. The School of Medicine, University of Nottingham and Clinical Engineering and Medical Physics Department, Nottingham University Hospitals (NUH) NHS Trust have provided conducive research environment for this work. Special thanks to Elaine Blackshaw for her help and for providing timely advice on the clinical trial design and application, as well as recruiting patients. I would like to thank Jeni Luckett for assisting me to acquire preclinical SPECT images. I am grateful to Helen Betts, Aristeidis Chiotellis, Ramla Awais, Helen Parker and Lina Yonekura for their help and friendship. The clinical trial undertaken in this thesis was led by Professor Alan C. Perkins and funded by Science Technology Facilities Council through CLASP Award. I would like to thank colleagues in the nuclear medicine clinic, including but not limited to Simon Lawes, Kevin Blackband, Mandy Blaze, Peter Hay, Clare Jacobs, Evelyn Shin and David Pye for their support and generosity in preparing radionuclides for the experimental work. Special thanks to Simon Lawes for his ever ready help whenever I looked for him especially in helping me to acquire SPECT-CT images. I would also like to acknowledge Mr. Kwok Leung Cheung for his expertise and invaluable information in guiding me to set up the new clinical trial for the use of the camera in SLNB, and to familiarise me with the surgical procedure. I am also grateful to the technical support provided by Clinical Engineering team. Thanks to David Clay and Micheal Jones for fabricating the bespoke phantoms that were needed in my experiment and providing the technical drawings. Special thanks to Beth Beeson for carrying out the medical device assessments in order to obtain approval Acknowledgement| viii for the HGC to be used in the clinical trial at NUH NHS Trust. I would also like to thank Jennifer Poveda, Mark Westby, Nick Gibson, Graham Love and Elizabeth Powell for their technical support. During my short trip to LUMC, I had the opportunity to work with Marieke Stammes, Hein Handgraaf and Pauline. Thanks for their hospitality and providing necessary research facilities for the preclinical imaging, including the mice with tumour model and the probe. I am grateful to Gamma Technologies Limited and Xstrahl Limited (Surrey, UK) for lending me the pre-production prototype Nebuleye, to LabLogic Systems Ltd. (Sheffield, UK) for allowing me to use CrystalCam gamma camera and to GE Healthcare (Arlington Heights, IL, USA) for providing the 125I seeds. I would like to express my gratitude and appreciation to the Ministry of Health and the Government of Malaysia for providing my PhD scholarship. Thanks to my colleagues in the MOH for your support and friendship. To my fellow office mates and friends: Thanks to everyone for sharing your laughter and support, in particular Dewen, Will, Stefan and Tom. Last but not least, I am extremely thankful to my family for their endless encouragement, care, trust and love.
Recommended publications
  • Design of Neutron and Gamma Ray Diagnostics for the Start-Up Phase of the DTT Tokamak
    46th EPS Conference on Plasma Physics P5.1105 Design of neutron and gamma ray diagnostics for the start-up phase of the DTT tokamak M. Angelone 1, D. Rigamonti 2, M Tardocchi 2, F. Causa 2, S. Fiore 1, L. C. Giacomelli 2, G. Gorini 3,2 , F. Moro 1, M. Nocente 3,2 , M. Osipenko 4, M. Pillon 1, , M. Ripani 4, R. Villari 1 1ENEA, Centro Ricerche Frascati, Frascati, Italy 2Istituto per la Scienza e Tecnologia dei Plasmi, CNR, Milan, Italy 3Dipart. di Fisica “G. Occhialini”, Università degli Studi di Milano-Bicocca, Milano, Italy 4Istituto Nazionale di Fisica Nucleare, Genova, Italy e-mail : [email protected] Abstract The Divertor Tokamak Test (DTT) facility, which is under design for construction in Frascati (Italy), will produce neutron yield up to 1.3*10 17 n/s at full power (H-mode scenario). This calls for an accurate design and selection of the 2.5 MeV neutron diagnostic systems and detectors which can give the comprehensive exploitation of the high neutron fluxes. Measurements of 14 MeV neutrons (which are about 1% of the total neutron yield) coming from the triton burn-up will also be performed. DTT will reach its best performances after a preliminary phase , needed to assess and improve the machine parameters. Here we present the neutron and gamma-ray diagnostics systems which are under design for the initial start-up phase of DTT. The design work benefits from the experience gathered by the community on high power tokamak such as JET. These systems, also called day-1 diagnostics, are: i) Neutron flux monitors which measure the 2.5 and 14 MeV neutron yield s, ii) Neutron/Gamma camera for the reconstruction of the neutron and gamma ray emission profile of the plasma , iii) Hard x-ray monitors for measurements of the bremsstrahlung radiation produced by runway electrons in the 1-40 MeV energy range 1.0 Introduction The Divertor Tokamak Test (DTT) facility, which is under design for construction in Frascati (Italy), will produce neutron yield up to 1.3*10 17 n/s at full power (H-mode scenario).
    [Show full text]
  • Radiation Quick Reference Guide Recommend Contacting Your State Fusion Center
    Domestic Nuclear Detection Office If you encounter something suspicious follow your specific local protocols. Radiation Quick Reference Guide Recommend contacting your state fusion center. DNDO is available 24/7 to assist at 1-877-DNDO-JAC / 1-877-363-6522 JAC Information Line 202-254-7179 Email: [email protected] Nuclear Concerns/ Threats 1. Nuclear Weapon - a device that releases nuclear energy in an ex- Isotopes of Concern for use in RDDs - with common uses plosive manner. Uses Highly Enriched Uranium (HEU) and/or 1. Cobalt-60 – cancer treatment, level/ Plutonium. density gauge, teletherapy, radiography, 2. Improvised Nuclear Device (IND) - a nuclear weapon fabricated food sterilization/irradiation, by a terrorist organization or rogue nation. brachytherapy 2. Iridium-192 – Radiography/non- destructive testing, flaw detection, brachy- therapy “cancer seed”, skin cancer Cobalt 60 sources Uranium “superficial” brachytherapy Plutonium 3. Uranium a. Uranium exists naturally in the earth’s crust. Of the different “isotopes” of uranium, U-235 is the one required to produce a Iridium sentinel and nuclear weapon. gamma camera b. Natural uranium contains a small amount of U-235 (<1%) which Cesium Seeds must be separated in complex extraction processes to create HEU. The predominant uranium isotope is U-238. 3. Cesium-137 - Gauge/level gauge, industrial radiography, brachyther- c. Highly Enriched Uranium (HEU) refers to uranium usable in weap- apy/teletherapy, well logging/density gauges ons due to its enrichment in U-235. 4. Strontium-90 – Radioisotope thermoelectric generator (RTG), fis- d. Approximately 25 kg of HEU is required for a nuclear weapon. sion product, industrial gauges, medical treatment e.
    [Show full text]
  • A New Gamma Camera for Positron Emission Tomography
    INIS-mf—11552 A new gamma camera for Positron Emission Tomography NL89C0813 P. SCHOTANUS A new gamma camera for Positron Emission Tomography A new gamma camera for Positron Emission Tomography PROEFSCHRIFT TER VERKRIJGING VAN DE GRAAD VAN DOCTOR AAN DE TECHNISCHE UNIVERSITEIT DELFT, OP GEZAG VAN DE RECTOR MAGNIFICUS, PROF.DRS. P.A. SCHENCK, IN HET OPENBAAR TE VERDEDIGEN TEN OVERSTAAN VAN EEN COMMISSIE, AANGEWEZEN DOOR HET COLLEGE VAN DECANEN, OP DINSDAG 20 SEPTEMBER 1988TE 16.00 UUR. DOOR PAUL SCHOTANUS '$ DOCTORANDUS IN DE NATUURKUNDE GEBOREN TE EINDHOVEN Dit proefschrift is goedgekeurd door de promotor Prof.dr. A.H. Wapstra s ••I Sommige boeken schijnen geschreven te zijn.niet opdat men er iets uit zou leren, maar opdat men weten zal, dat de schrijver iets geweten heeft. Goethe Contents page 1 Introduction 1 2 Nuclear diagnostics as a tool in medical science; principles and applications 2.1 The position of nuclear diagnostics in medical science 2 2.2 The detection of radiation in nuclear diagnostics: 5 standard techniques 2.3 Positron emission tomography 7 2.4 Positron emitting isotopes 9 2.5 Examples of radiodiagnostic studies with PET 11 2.6 Comparison of PET with other diagnostic techniques 12 3 Detectors for positron emission tomography 3.1 The absorption d 5H keV annihilation radiation in solids 15 3.2 Scintillators for the detection of annihilation radiation 21 3.3 The detection of scintillation light 23 3.4 Alternative ways to detect annihilation radiation 28 3-5 Determination of the point of annihilation: detector geometry,
    [Show full text]
  • Gamma Cameras
    OECD Health Statistics 2021 Definitions, Sources and Methods Gamma cameras Number of Gamma cameras. A Gamma camera (including Single Photon Emission Computed Tomography, SPECT) is used for a nuclear medicine procedure in which the camera rotates around the patient to register gamma rays emission from an isotope injected to the patient's body. The gathered data are processed by a computer to form a tomographic (cross-sectional) image. Inclusion - SPECT-CT systems using image fusion (superposition of SPECT and CT images). Sources and Methods Australia Source of data: Department of Health. Unpublished data from Location Specific Position Number register. Reference period: Years reported are financial years 1st July to 31st June (e.g. data for 2012 are as at 30th June 2012). Coverage: Data from 2008 onwards represent the number of units approved for billing to Medicare only. Units may be removed from one location and re-registered in another location. Austria Source of data: Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection / Gesundheit Österreich GmbH, Monitoring of medical technology development. Reference period: 31st December. Coverage: - Included are all Gamma cameras units in hospitals as defined by the Austrian Hospital Act (KAKuG) and classified as HP.1 according to the System of Health Accounts (OECD). - The ambulatory sector is included (HP.3). Belgium Source of data: Federal Service of Public Health, DGGS “Organisation of health provisions”; Ministry of the Flemish community and Ministry of the French community. Coverage: - Ambulatory care providers (HP.3): Data on high-tech equipment in cabinets of ambulatory care providers are not available.
    [Show full text]
  • State-Of-The-Art Mobile Radiation Detection Systems for Different Scenarios
    sensors Review State-of-the-Art Mobile Radiation Detection Systems for Different Scenarios Luís Marques 1,* , Alberto Vale 2 and Pedro Vaz 3 1 Centro de Investigação da Academia da Força Aérea, Academia da Força Aérea, Instituto Universitário Militar, Granja do Marquês, 2715-021 Pêro Pinheiro, Portugal 2 Instituto de Plasmas e Fusão Nuclear, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais 1, 1049-001 Lisboa, Portugal; [email protected] 3 Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10 (km 139.7), 2695-066 Bobadela, Portugal; [email protected] * Correspondence: [email protected] Abstract: In the last decade, the development of more compact and lightweight radiation detection systems led to their application in handheld and small unmanned systems, particularly air-based platforms. Examples of improvements are: the use of silicon photomultiplier-based scintillators, new scintillating crystals, compact dual-mode detectors (gamma/neutron), data fusion, mobile sensor net- works, cooperative detection and search. Gamma cameras and dual-particle cameras are increasingly being used for source location. This study reviews and discusses the research advancements in the field of gamma-ray and neutron measurements using mobile radiation detection systems since the Fukushima nuclear accident. Four scenarios are considered: radiological and nuclear accidents and emergencies; illicit traffic of special nuclear materials and radioactive
    [Show full text]
  • Radiation and Radionuclide Measurements at Radiological and Nuclear Emergencies
    Radiation and radionuclide measurements at radiological and nuclear emergencies. Use of instruments and methods intended for clinical radiology and nuclear medicine. Ören, Ünal 2016 Document Version: Publisher's PDF, also known as Version of record Link to publication Citation for published version (APA): Ören, Ü. (2016). Radiation and radionuclide measurements at radiological and nuclear emergencies. Use of instruments and methods intended for clinical radiology and nuclear medicine. Lund University: Faculty of Medicine. Total number of authors: 1 Creative Commons License: Other General rights Unless other specific re-use rights are stated the following general rights apply: Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal Read more about Creative commons licenses: https://creativecommons.org/licenses/ Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. LUND UNIVERSITY PO Box 117 221 00 Lund +46 46-222 00 00 Download date: 24. Sep. 2021 Radiation and radionuclide measurements at radiological and nuclear emergencies Use of instruments and methods intended for clinical radiology and nuclear medicine Ünal Ören DOCTORAL DISSERTATION by due permission of the Faculty of Medicine, Lund University, Sweden.
    [Show full text]
  • Recent Advances in Multi-Modality Molecular Imaging of Small Animals
    8/3/2016 Recent Advances in Multi-modality Molecular Imaging of Small Animals Benjamin M. W. Tsui, Ph.D. Department of Radiology August 3, 2016 1 Outline Introduction Early developments of molecular imaging (MI) of small animals (SA) Development of multi-modality MI of SA – Instrumentation – Image reconstruction and processing methods Recent advances Comparing Biomedical Imaging Techniques US MRI X-ray CT SPECT PET OPTICAL Anatomical Yes Yes Yes No No No Functional Yes Yes No Yes Yes Yes Resolution Sub- Sub- Sub- <1 mm ~1 mm Sub- millimeter millimeter millimeter (0.6 – 0.3mm) micron Molecular No Good No Excellent Excellent Excellent Target Molecular targeting No Poor No Good Excellent Poor sensitivity Translational Yes Yes Yes Yes Yes No 1 8/3/2016 Traditional Nuclear Medicine Imaging Techniques an important function imaging modality Activity labels tracer or biomarkers w/ radioisotope distribution administers radio-tracer into patient Gamma detects photon emissions using position- photons sensitive detectors Collimator Provides localization & biodistribution information of radiotracers - e.g., perfusion, potassium analog, monoclonal antibody Scintillation Clinical applications crystal Scintillation - e.g., cardiac and kidney functions, cancer Camera Positioning Photomultiplier detection, neurological disorders circuitry tube array EMISSION COMPUTED TOMOGRAPHY (ECT) an important function imaging modality Nuclear imaging combined with computed tomography (Image reconstruction from multiple projections) Categories of ECT - PET
    [Show full text]
  • Positron Emission Tomography
    Positron emission tomography A.M.J. Paans Department of Nuclear Medicine & Molecular Imaging, University Medical Center Groningen, The Netherlands Abstract Positron Emission Tomography (PET) is a method for measuring biochemical and physiological processes in vivo in a quantitative way by using radiopharmaceuticals labelled with positron emitting radionuclides such as 11C, 13N, 15O and 18F and by measuring the annihilation radiation using a coincidence technique. This includes also the measurement of the pharmacokinetics of labelled drugs and the measurement of the effects of drugs on metabolism. Also deviations of normal metabolism can be measured and insight into biological processes responsible for diseases can be obtained. At present the combined PET/CT scanner is the most frequently used scanner for whole-body scanning in the field of oncology. 1 Introduction The idea of in vivo measurement of biological and/or biochemical processes was already envisaged in the 1930s when the first artificially produced radionuclides of the biological important elements carbon, nitrogen and oxygen, which decay under emission of externally detectable radiation, were discovered with help of the then recently developed cyclotron. These radionuclides decay by pure positron emission and the annihilation of positron and electron results in two 511 keV γ-quanta under a relative angle of 180o which are measured in coincidence. This idea of Positron Emission Tomography (PET) could only be realized when the inorganic scintillation detectors for the detection of γ-radiation, the electronics for coincidence measurements, and the computer capacity for data acquisition and image reconstruction became available. For this reason the technical development of PET as a functional in vivo imaging discipline started approximately 30 years ago.
    [Show full text]
  • ITER Relevant Runaway Electron Studies in the FTU Tokamak
    ITER Relevant Runaway Electron Studies in the FTU Tokamak by Zanaˇ Popovi´c A dissertation submitted in partial fulfilment of the requirements for the degree of Doctor of Philosophy in Plasmas y Fusi´on Nuclear Universidad Carlos III de Madrid Directors: Prof Dr Jos´eRam´on Mart´ın Sol´ıs Dr Basilio Esposito Tutor: Prof Dr Jos´eRam´on Mart´ın Sol´ıs July 2019 Esta tesis se distribuye bajo licencia “Creative Commons Reconocimiento – No Comercial – Sin Obra Derivada” ii Dedication To my family, VVBM iii iv Acknowledgements I would like to thank an exceptional man, my thesis director and supervisor Prof Jos´eRam´on Mart´ın Sol´ıs. I have been lucky to be his student and am very grateful for all the help and caring guidance he has given me, for his patience and organisation throughout this work, especially during one of the most challenging years I have had. I appreciate immensely his expertise and dedication to teaching, which made this thesis possible. I would also like to thank my thesis co-director, Dr Basilio Esposito, for the invaluable mentoring and direction over the years, and for the delightful hospitality he and his family provided during my research visits in Frascati. Many thanks to the people I collaborated with as a part of the FTU team at ENEA Research Centre, especially Drs Daniele Carnevale, Daniele Marocco, Federica Causa and Mateusz Gospodarczyk, as well as the other members of the FTU team and supporting staff for creating a stimulating and cheerful work environment during long experiments. This journey was filled with interesting times spent with the people from the Department of Physics at Universidad Carlos III de Madrid.
    [Show full text]
  • Preclinical SPECT Imaging Based on Compact Collimators and High Resolution Scintillation Detectors
    Preklinische SPECT-beeldvorming gebaseerd op compacte collimatoren en hogeresolutiescintillatiedetectoren Preclinical SPECT Imaging Based on Compact Collimators and High Resolution Scintillation Detectors Karel Deprez Promotoren: prof. dr. S. Vandenberghe, prof. dr. R. Van Holen Proefschrift ingediend tot het behalen van de graad van Doctor in de Ingenieurswetenschappen Vakgroep Elektronica en Informatiesystemen Voorzitter: prof. dr. ir. J. Van Campenhout Faculteit Ingenieurswetenschappen en Architectuur Academiejaar 2013 - 2014 ISBN 978-90-8578-672-6 NUR 954, 959 Wettelijk depot: D/2014/10.500/18 Department of Electronics and Information Systems Medical Image and Signal Processing (MEDISIP) Faculty of Engineering and Architecture Ghent University MEDISIP IBiTech Campus Heymans, Blok B De Pintelaan 185 9000 Ghent Belgium Promotors Prof. dr. Stefaan Vandenberghe Prof. dr. Roel Van Holen Board of examiners Prof. dr. ir. Patrick De Baets, Ghent University, chairman Dr. Michael Tytgat, Ghent University / CERN, secretary Prof. dr. Luc Van Hoorebeke, Ghent University Prof. dr. Dennis Schaart, Delft University of Technology, The Netherlands Prof. dr. Carlo Fiorini, Politecnico di Milano, Italy Dr. Samuel Espana˜ Palomares, Advanced Imaging Unit, Centro Nacional de Inves- tigaciones Cardiovasculares (CNIC), Spain Dr. Peter Bruyndonckx, Bruker MicroCT, Belgium This work was supported by the 7th Framework Programme (FP7) of the European Union through the SUBLIMA project (Grant Agreement No 241711) Acknowledgements The work presented in this dissertation started in 2008, shortly after the birth of my daughter, and was finished in early 2014. Before I started at the university I had been working for several years as a electronics design engineer at Barco and Gemidis. The first thing that struck me when I started at the university was the content of my work.
    [Show full text]
  • Medical Nuclear Physics Performance Monitoring of Gamma Cameras
    The American College of Radiology, with more than 30,000 members, is the principal organization of radiologists, radiation oncologists, and clinical medical physicists in the United States. The College is a nonprofit professional society whose primary purposes are to advance the science of radiology, improve radiologic services to the patient, study the socioeconomic aspects of the practice of radiology, and encourage continuing education for radiologists, radiation oncologists, medical physicists, and persons practicing in allied professional fields. The American College of Radiology will periodically define new practice parameters and technical standards for radiologic practice to help advance the science of radiology and to improve the quality of service to patients throughout the United States. Existing practice parameters and technical standards will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner, if indicated. Each practice parameter and technical standard, representing a policy statement by the College, has undergone a thorough consensus process in which it has been subjected to extensive review and approval. The practice parameters and technical standards recognize that the safe and effective use of diagnostic and therapeutic radiology requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice parameter and technical standard by those entities not providing these services is not authorized. 2018 (CSC/BOC)* ACR–AAPM TECHNICAL STANDARD FOR NUCLEAR MEDICAL PHYSICS PERFORMANCE MONITORING OF GAMMA CAMERAS PREAMBLE This document is an educational tool designed to assist practitioners in providing appropriate radiologic care for patients. Practice Parameters and Technical Standards are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care1.
    [Show full text]
  • (EANM) Acceptance Testing for Nuclear Medicine Instrumentation
    Eur J Nucl Med Mol Imaging (2010) 37:672–681 DOI 10.1007/s00259-009-1348-x GUIDELINES Acceptance testing for nuclear medicine instrumentation Ellinor Busemann Sokole & Anna Płachcínska & Alan Britten & on behalf of the EANM Physics Committee Published online: 5 February 2010 # EANM 2010 Keywords Quality control . Quality assurance . requirement that acceptance testing be performed should Acceptance testing . Nuclear medicine instrumentation . be included in the purchase agreement of an instrument. Gamma camera . SPECT. PET. CT. Radionuclide calibrator. This agreement should specify responsibilities regarding Thyropid uptake probe . Nonimaging intraoperative probe . who does acceptance testing, the procedure to be followed Gamma counting system . Radiation monitors . when unsatisfactory results are obtained, and who supplies Preclinical PET the required phantoms and software. A specific time slot must be allocated for performing acceptance tests. Introduction Acceptance and reference tests These recommendations cover acceptance and reference tests that should be performed for acceptance testing of Acceptance tests are performed to verify that the instrument instrumentation used within a nuclear medicine department. performs according to its specifications. Each instrument is These tests must be performed after installation and before supplied with a set of basic specifications. These have been the instrument is put into clinical use, and before final produced by the manufacturer according to standard test payment for the device. These recommendations
    [Show full text]